Applied DNA Sciences Inc
NASDAQ:APDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genovis AB
STO:GENO
|
SE |
|
McLeod Russel India Ltd
NSE:MCLEODRUSS
|
IN |
|
Infracommerce CXAAS SA
BOVESPA:IFCM3
|
BR |
Applied DNA Sciences Inc
Other Current Liabilities
Applied DNA Sciences Inc
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
Other Current Liabilities
$136.9k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-4%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Current Liabilities
$2.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Current Liabilities
$1.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Waters Corp
NYSE:WAT
|
Other Current Liabilities
$532.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Current Liabilities
$682m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Current Liabilities
$2.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
Applied DNA Sciences Inc
Glance View
Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
See Also
What is Applied DNA Sciences Inc's Other Current Liabilities?
Other Current Liabilities
136.9k
USD
Based on the financial report for Jun 30, 2025, Applied DNA Sciences Inc's Other Current Liabilities amounts to 136.9k USD.
What is Applied DNA Sciences Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-4%
Over the last year, the Other Current Liabilities growth was 167%. The average annual Other Current Liabilities growth rates for Applied DNA Sciences Inc have been -43% over the past three years , -20% over the past five years , and -4% over the past ten years .
